Pharmaceutical Supply – Medroxyprogesterone Acetate Injectable Suspension
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the supply and delivery of two units of Medroxyprogesterone Acetate Injectable Suspension identified by NSN 6505015295618, with full compliance required to federal and Department of Defense pharmaceutical standards. This subcontract, issued under the NAICS code 424210 for Pharmaceutical and Biological Product Merchant Wholesalers, is managed by the Defense Logistics Agency within the Department of Defense. The posting date is July 16, 2026, indicating the solicitation is anticipated for future award. The place of performance and specific delivery location are not detailed in the provided data, and no point of contact information is listed. The contract award details can be referenced through the official DIBBS link provided, which contains the full award record and transactional information.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2D226F3037.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
MEDROXYPROGESTERONE ACETATE INJECTABLE S
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
